Ask AI

Optimizing PARPi in Ovarian Cancer: Practical Guidance on Current Clinical Management Strategies

Review the latest data and expert guidance on PARP inhibitors to enhance your treatment of ovarian cancer. This comprehensive program features decision support tools focused commentaries an expert analysis module and a downloadable slideset.

Share

Program Content

Activities

QUADRA Trial Implications
My Thoughts on the Clinical Implications of the Expanded Indication for Niraparib
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 26, 2019

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by independent educational grants from

Clovis Oncology

Tesaro